Hostname: page-component-54dcc4c588-sq2k7 Total loading time: 0 Render date: 2025-10-09T19:38:02.001Z Has data issue: false hasContentIssue false
  • English
  • Français

The Relationship Between Metabolic Syndrome and Psychological Resilience in Schizophrenia Patients in Remission

Published online by Cambridge University Press:  26 August 2025

Ö. Kaya Tuncel ,
D. İpekçioğlu  and
S. Uysal Atasoy
Ö. Kaya Tuncel*
Affiliation:
Psychiatry, Republic of Turkey Ministry of Health Ordu State Hospital, Ordu
D. İpekçioğlu
Affiliation:
Psychiatry, Bakırköy Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, İstanbul, Türkiye
S. Uysal Atasoy
Affiliation:
Psychiatry, Bakırköy Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, İstanbul, Türkiye
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Comprehending metabolic syndrome (MetS) risk factors in schizophrenia patients is pivotal for devising effective treatment strategies.

Objectives

This study aims to explore the relationship between MetS and psychological resilience in schizophrenia patients.

Methods

A total of 140 schizophrenia patients with no hospital admissions or treatment changes in the last 6 months were enrolled in the study. For metabolic syndrome screening, patients’ blood pressure, height, weight, waist circumference, and hip circumference measurements were taken; these data, along with blood lipid levels and fasting glucose, were recorded on the sociodemographic and clinical data form. Patients were categorized into two groups based on the presence or absence of MetS. The Positive and Negative Syndrome Scale (PANSS) and the Resilience Scale for Adults were applied cross-sectionally.

Results

MetS was identified in 33.6% of the included patients, with 88.6% exhibiting abdominal obesity. There were no statistically significant differences between groups in terms of gender, marital status, education level, employment status, type of antipsychotic, and use of single or multiple antipsychotics. In the MetS group, PANSS negative symptom scores were significantly higher. No significant differences were observed in psychological resilience between the groups.

Image 1:

Conclusions

The demonstration of the relationship between the presence of MetS and the severity of negative symptoms is one of the significant outcomes of our study. These outcomes may contribute to formulating personalized treatment approaches.

Disclosure of Interest

None Declared

Information

Type
Abstract
Information
European Psychiatry , Volume 68 , Special Issue S1: Abstracts of the 33rd European Congress of Psychiatry , April 2025 , pp. S1101
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.